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This review examines two aspects of the structure and function of mitochondrial Complex I (NADH Coenzyme Q oxidoreductase) that have
become matter of recent debate.The supramolecular organization of Complex I and its structural relation with the remainder of the respiratory
chain are uncertain. Although the random diffusion model [C.R. Hackenbrock, B. Chazotte, S.S. Gupte, The random collision model and a critical
assessment of diffusion and collision in mitochondrial electron transport, J. Bioenerg. Biomembranes 18 (1986) 331–368] has been widely
accepted, recent evidence suggests the presence of supramolecular aggregates. In particular, evidence for a Complex I–Complex III supercomplex
stems from both structural and kinetic studies. Electron transfer in the supercomplex may occur by electron channelling through bound Coenzyme
Q in equilibrium with the pool in the membrane lipids. The amount and nature of the lipids modify the aggregation state and there is evidence that
lipid peroxidation induces supercomplex disaggregation. Another important aspect in Complex I is its capacity to reduce oxygen with formation of
superoxide anion. The site of escape of the single electron is debated and either FMN, iron–sulphur clusters, and ubisemiquinone have been
suggested. The finding in our laboratory that two classes of hydrophobic inhibitors have opposite effects on superoxide production favours an
iron–sulphur cluster (presumably N2) is the direct oxygen reductant.The implications in human pathology of better knowledge on these aspects of
Complex I structure and function are briefly discussed.
© 2006 Elsevier B.V. All rights reserved.Keywords: Complex I; Supercomplex; Coenzyme Q; ROS; Rotenone; Stigmatellin1. Introduction
Complex I is a very large enzyme catalyzing the first step of
the mitochondrial electron transport chain [1,2]. The enzyme
oxidizes NADH transferring electrons to Ubiquinone (Coen-
zyme Q, CoQ), a lipid soluble electron carrier embedded in the
lipid bilayer of the inner mitochondrial membrane. The total
number of subunits in the bovine enzyme is 46 [3] for aAbbreviations: AIF, apoptosis-inducing factor; BN-PAGE, blue-native
polyacrylamide gel electrophoresis; CIA30, Complex I intermediate-associated
protein30; CIA84, Complex I intermediate-associated protein84; CL, cardioli-
pin; CoQ, Coenzyme Q; DCIP, dichlorophenol indophenol; DPI, diphenylene
iodonium; EPR, Electron Paramagnetic Resonance; LHON, Leber’s Hereditary
Optic Neuropathy; mtDNA, mitochondrial DNA; NDUFAF1, NADH dehydro-
genase (ubiquinone) 1 alpha subcomplex assembly factor 1; NDUFS4, NADH
dehydrogenase (ubiquinone) Fe–S protein 4; OXPHOS, oxidative phosphory-
lation; ROS, reactive oxygen species
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doi:10.1016/j.bbabio.2006.05.007molecular mass of about 1000 kDa. Seven subunits are the
products of the mitochondrial genome [4,5] and correspond to
hydrophobic components named ND1–ND6 and ND4L. The
minimal active form of the enzyme is that found in bacteria,
composed of 14 subunits, all of which are homologous to their
mitochondrial counterparts, while all other subunits are called
“accessory subunits” and their role in the mitochondrial enzyme
is not clear. From structural and phylogenetic considerations,
the enzyme is envisaged to consist of three different sectors: a
dehydrogenase unit and a hydrogenase-like unit constituting the
peripheral arm protruding into the matrix, and a transporter unit
deeply embedded in the membrane [6,7].
The enzyme is endowed with several prosthetic groups:
FMN is the entry point for electrons from NADH, that are then
transferred to the iron–sulphur clusters [8]. Enzymes from
different sources have different numbers of iron–sulphur
clusters, most of which share the same midpoint potential and
are called “isopotential” clusters. Two clusters present different
characteristics: N1a, that is of the kind Fe2S2, has the lowest
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Fe4S4, resides at the interface between the 22 kDa subunit PSST
and the 49 kDa subunits [9] and has the highest midpoint
potential (Em between −150 mVand −50 mV), presenting EPR
magnetic interactions with the ubisemiquinone radicals; for
these reasons, it is considered to be the direct electron donor to
ubiquinone [10]. N2 iron–sulphur cluster is most likely located
in the connection between the peripheral and the membrane
arm. The magnetic interaction with the semiquinone radical,
corresponding to a distance of about 10 Å [11,12], suggests that
the ubiquinone headgroup could somehow reach up into the
peripheral arm as recently assumed by Brandt et al. [13] , who
have hypothesized an amphipathic ‘ramp’ guiding ubiquinone
into the catalytic site. Recently the arrangement of iron–sulphur
clusters in the hydrophilic domain of Complex I from T.
thermophilus has been determined by X-ray crystallography,
showing a linear chain of all clusters except N1a and N7 [14]. A
schematic picture of the enzyme is depicted in Fig. 1.
Complex I is inhibited by more than 60 different families of
compounds [15] starting from Rotenone, the prototype of this
series, to a number of synthetic insecticides/acaricides. These
inhibitors were grouped into three classes based on their effects
on the kinetic behaviour of the enzyme: Class I/A (the prototype
of which is Piericidin A), Class II/B (the prototype of which is
Rotenone) and Class C (the prototype of which is Capsaicin).
Nevertheless from kinetic studies it was not possible to assign
different binding sites for these three classes of inhibitors: it is
commonly accepted that they share the same hydrophobic large
pocket in the enzyme [16].
Complex I is also involved in the formation of the trans-
membrane proton gradient with a stoichiometry of 4 H+/2e−.
The limited knowledge about the structure and the function of
Complex I makes it difficult to predict the mechanism by which
this respiratory chain complex uses redox energy to translocate
protons across the inner mitochondrial membrane (for a review,
see [17]).
Besides its well-known redox role in the electron transport
chain, Complex I is considered one of the main sites of reactive
oxygen species (ROS) production: electron leaks at Complex I
can release single electrons to oxygen and give rise to su-
peroxide anion. The mechanism of superoxide production byFig. 1. Schematic picture of Complex I in the inner mitochondrial membrane.
The figure is freely redrawn from Brandt et al. [13].Complex I is not clear, probably for lack of knowledge of the
exact sequence of the electron carriers and how electron transfer
is coupled to proton translocation. The major sites of ROS pro-
duction in the mitochondrial electron transport chain have been
localized in Complex I and Complex III [18]; while the site of
electron escape in Complex III has been identified in the so
called center “o”, the direct oxygen reductant site in Complex I
is not known with certainty [19].
The notion of Complex I as an individual enzyme stems out of
its isolation as a discrete lipoprotein unit by detergent fractiona-
tion [20]. In spite of the above prevalent view, two extreme con-
ditions can be envisaged on theoretical grounds, and have indeed
been proposed, for the organization of the respiratory chain [21].
In the first view, the chain is organized in a liquid state. The large
enzymatic complexes are randomly distributed in the plane of the
membrane, where they move freely by lateral diffusion. Ubiqui-
none and cytochrome c are also mobile electron carriers, whose
diffusion rate is faster than that of the bulkier protein complexes.
Alternatively, the components of the chain are envisaged to be in
the form of aggregates, ranging from small clusters of few com-
plexes to the extreme of a solid-state assembly. The aggregates
may be either permanent or transient, but their duration in time
must be larger than any electron transfer turnover in order to
show kinetic differences from the previous model. Recent struc-
tural and kinetic evidence strongly suggests that Complexes I
and III form stable functional supercomplexes [22,23].
In this mini-review, we focalize on two aspects of Complex I:
(a) its relationship with the remainder of the respiratory chain,
analyzing available evidence for the existence of a super-com-
plex I–III; (b) the mechanism of electron transfer in the acceptor
quinone region of the Complex, exploited by elucidation of the
mechanism of oxygen reduction to superoxide radical. Both
aspects are particularly relevant to human pathology, and some
hints on pathological implications will be given in this review.
2. Supramolecular organization of Complex I
2.1. Structural and kinetic evidence for supercomplexes
A great deal of structural, biophysical and enzyme kinetics
studies in the past have addressed the problem of the supra-
molecular organization of the respiratory chain, until the
random collision model proposed by Hackenbrock [24] was
accepted by the majority of investigators in the field, in spite of
several findings raising doubts on the universal validity of the
model.Experimental evidence pertaining to the problem of
supramolecular organization with pros and cons the random
collision model and related references is exhibited in Table 1.
The random collision model was proposed on the basis of direct
investigation of themobility ofmitochondrial components by either
electrophoretic relaxation or FRAP (fluorescence recovery after
photobleaching), yielding lateral diffusion coefficients in the range
between 10−9 and 10−10 cm2/s for mitochondrial membrane
complexes [24] and higher than 10−9 cm2/s for CoQ [24,25]. The
first proposal that CoQ functions as a mobile electron carrier was
given by Green [20] on the basis of the isolation of discrete
lipoprotein complexes of the respiratory chain, of which the
Table 1
Structural and kinetic evidence related to the organization of the mitochondrial respiratory chain
Experimental analysis Evidence Reference
Ultrastructural morphological appearance
of the inner mitochondrial membrane
Supercomplex assembly S. Fleischer et al. (1967) [146]
Random distribution E. Sowers & C.R. Hackenbrock (1981) [147]
Random distribution C.R. Hackenbrock et al. (1986) [24]
Supercomplex assembly T. Ozawa et al. (1987) [34]
Isolation of enzyme complexes Supercomplex assembly Y. Hatefi et al. (1962) [148]
Supercomplex assembly A. Yu & L. Yu (1980) [149]
Supercomplex assembly E.A. Berry & B.L. Trumpower (1985) [150]
Supercomplex assembly T. Ozawa et al. (1987) [34]
Supercomplex assembly N. Sone et al. (1987) [151]
Supercomplex assembly T. Iwasaki et al. (1995) [152]
Reconstitution of respiratory complexes
in lipid vesicles
Supercomplex assembly C.I. Ragan & C. Heron (1978) [57]
Supercomplex assembly C. Heron et al. (1978) [61]
Mobility of mitochondrial complexes
(electrophoretic relaxation, ER; FRAP)
Random distribution S. Kawato et al. (1981) [153]
Random distribution E. Sowers & C.R. Hackenbrock (1981, 1985) [154,155]
Random distribution H. Schneider et al. (1982) [33]
Random distribution S.S. Gupte & C.R. Hackenbrock (1988) [156]
Random distribution G. Lenaz (1988) [21]
Kinetic analysis of steady state respiration Random distribution A. Kröger & M. Klingenberg (1973) [26]
Random distribution R.J. Froud & C.I. Ragan (1984) [157]
Random distribution M. Gutman (1985) [27]
Random distribution C.I. Ragan & I.R. Cottingham (1985) [28]
Random distribution R. Fato et al. (1996) [112]
Supercomplex assembly C. Bianchi et al. (2003) [66]
Saturation kinetics of electron transfer Random distribution B. Norling et al. (1974) [158]
Random distribution H. Schneider et al. (1982) [33]
Random distribution G. Lenaz et al. (1986, 1989, 1997) [25,30,159]
Random distribution E. Estornell et al. (1992) [29]
Double inhibitor titration Random distribution for Complex II–III,
Supercomplex assembly for Complex III–IV
B. Stoner (1984) [58]
Calorimetric and spin label EPR analysis
of the interaction between complexes
Supercomplex assembly for Complex II–III S.H. Gwak (1986) [160]
Gel electrophoresis Supercomplex assembly C.M. Cruciat et al. (2000) [37]
Supercomplex assembly H. Schägger et al. (2001, 2004) [39,44]
Random distribution for Complex II H. Schägger & K. Pfeiffer (2001) [39]
Random distribution for Complex II H. Eubel et al. (2003) [47]
Supercomplex assembly H. Eubel et al. (2004) [46]
Supercomplex assembly R. Acin-Perez et al. (2004) [48]
Supercomplex assembly N.V. Dudkina et al. (2005) [45]
Flux control analysis Supercomplex assembly H. Boumans et al. (1998) [35]
Supercomplex assembly
Random distribution for Complex II and IV
C. Bianchi et al. (2004) [23]
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groups in the complexes, and was subsequently supported by the
kinetic analysis of Kröger and Klingenberg [26]; they showed that
steady-state respiration in submitochondrial particles from beef
heart could be modelled as a simple two-enzyme system, the first
causing reduction of ubiquinone and the second causing oxidation
of ubiquinol. If diffusion of the quinone and quinol species is much
faster than the chemical reactions of CoQ reduction and oxidation,
the quinone behaves kinetically as a homogeneous pool. According
to this assumption, during steady-state electron transfer, the overall
flux observed (Vobs) will be determined by the redox state of the
quinone and described by the pool equation [26]
Vobs ¼ ðVreddVoxÞ=ðVred þ VoxÞ: ð1Þ
This expression was verified under a wide variety of input and
output rates and establishes that CoQ distributes electrons ran-
domly among the dehydrogenases and the bc1 complexes, beha-ving indeed as a freely diffusible intermediate. The hyperbolic
relation of electron flux on the rate of either CoQ reduction (Vred)
or CoQH2 oxidation (Vox) was confirmed in a variety of systems
[27,28].
If the CoQ concentration is not saturating for the activity of the
reducing and oxidizing enzymes, the equation is modified [28] by
feeding it in the Michaelis–Menten equation for enzyme kinetics,
taking into account total CoQ concentration [Qt], the individual
Vmax of the dehydrogenase and Complex III and their dissociation
constants for reduced and oxidized CoQ, respectively. Vobs is
hyperbolically related to [Qt] and maximal turnovers of electron
transfer are attained only at [Qt] saturating both Vred and Vox [25].
Direct titrations of CoQ-depleted mitochondria reconstituted
with different CoQ supplements yielded a Km of NADH oxi-
dation forQt in the range of 2–5 nmol/mg mitochondrial protein
[29], corresponding to a Qt concentration of 4–10 mM in the
lipid bilayer. The Km in the composite system is a poised func-
tion of Vmax and dissociation constants for CoQ of the
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changes of the complexes linked by the CoQ-pool, but is
anyway an important parameter, in that it is operationally
described as the Qt concentration yielding half-maximal
velocity of integrated electron transfer Vobs [30]. Analysis of
the literature shows that the physiological CoQ content of
several types of mitochondria [31] is in the range of the Km for
NADH oxidation, and therefore not saturating for this activity.
The relation between electron transfer rate and CoQ con-
centration was observed in reconstituted systems and in phos-
pholipid-enriched mitochondria for NADH oxidation [32,33].
In spite of this evidence, the idea of preferential associations
and of specific aggregates of electron transfer complexes has
never been abandoned (cf. [34–36]).
More recently, Cruciat [37] and Schägger [38,39] have pro-
duced convincing evidence of multicomplex units in yeast and
mammalian mitochondria introducing a quantitative approach: a
mild one-step separation protocol for the isolation of membrane
protein complexes, namely blue native polyacrylamide gel elec-
trophoresis (BN-PAGE). In bovine heart mitochondria Complex
I–III, interactions were detected from the presence of high mole-
cular weight aggregates suggesting the existence of a super-
complex containing one copy of Complex I and two copies of
Complex III, i.e., I1III2, that was found further assembled into two
major supercomplexes (respirasomes) comprising different copy
numbers of Complex IV (I1III2IV2 and I1III2IV4). Only 14–16%
of total Complex I was found in free form in the presence of
digitonin [39]; it seems therefore likely that all Complex I is
bound to Complex III in physiological conditions (i.e., in the
absence of detergents). Knowing the accurate stoichiometry of
oxidative phosphorylation complexes according to [39], the ave-
rage ratio I:II:III:IV:V is 1.1:1.3:3.0:6.7:3.5: it is then plausible
that approximately one third of total Complex III in bovine mito-
chondria is not bound to monomeric Complex I. Associations of
Complex II with other complexes of the OXPHOS system could
not be identified under the conditions of BN-PAGE so far.
BN-PAGE has become a popular experimental strategy for
the structural analysis of the protein-complex composition of
the respiratory chain in different systems. Based on this proce-
dure, the existence of respirasome-like supercomplexes was
also reported for bacteria [40], fungi [41] and higher plant mi-
tochondria [42,43] as well as for human mitochondria [44].
The I–III supercomplex proved to be especially stable. De-
pending on the plant investigated, 50–90% of Complex I forms
part of the I1III2 supercomplex in Arabidopsis [45], potato [46],
bean and barley [47] upon solubilisation of isolated mitochon-
dria by nonionic detergents; whereas Complex IV-containing
supercomplexes are of low abundance (bound Complex IV is
b10%) and Complex II clearly is not associated, even in plants.
The first chromatographic isolation of a complete respirasome
(I1III4IV4) from digitonin-solubilised membranes of Paracoccus
denitrificans indicated that Complex I is stabilized by assembly
into the NADH oxidase supercomplex, since attempts to isolate
Complex I frommutant strains lacking Complexes III or IV led to
the complete dissociation of Complex I under the conditions of
BN-PAGE. Reduced stability of Complex I in those mutant
strains was also apparent from an almost complete loss of NADH:ubiquinone oxidoreductase activity when the same protocol as for
parental strain was applied [40].
Analysis of the state of supercomplexes in human patientswith a
primary Complex III deficiency [44] and in cultured cell models
harbouring cytochrome b mutations [48] also provided evidence
that the formation of respirasomes is essential for the assembly/
stability of Complex I. Genetic alterations leading to a loss of
Complex III prevented respirasome formation and led to secondary
loss of Complex I, therefore primary Complex III assembly defi-
ciencies presented as Complex III/I defects. Conversely, Complex
III stability was not influenced by the absence of Complex I.
A question that remains to be solved is how the influence of
Complex III on Complex I is exerted. In this respect, deeper
analytical research is needed to clearly explain the structural
linkage between the two enzymes in the supercomplex assembly.
Recently, Dudkina et al. [45] presented a model for how
complexes I and III are spatially organized within a stable I1III2
supercomplex purified from isolated Arabidopsismitochondria.
Structural characterisation by single-particle Electron Micros-
copy at a resolution of 18Å revealed a specific lateral association
of dimeric Complex III to the tip of the hydrophilic portion of
Complex I within the membrane plane. Because negative stain
does not penetrate the hydrophobic parts, direct evidence of the
membrane-embedded architecture is lacking. Although it is not
known which subunits of Complex I constitute the tip, 3D mo-
delling indicated that subunit 9 of Complex III is closest to the
interface; whereas the very bulky matrix-protruding domains of
both complexes appear in one another's vicinity but are not
(strongly) interacting.
Future investigations of the exact composition of Complex I and
of its assembly process will probably enhance our understanding of
the natural form of the I–III supercomplex. Indeed, it is known that
mitochondrial Complex I assembles through the combination of
evolutionary conservedmodules [49] and that the precise hierarchy
throughwhich each of the nascent subunits interact, refold, and self-
assemble to generate multipart building blocks can be modulated
by several proteins chaperones [44,50,51] It is quite conceivable
that, analogous to recent examples of assembly factors for Complex
I (i.e., CIA30, CIA84, NDUFAF1, AIF, NDUFS4), additional
proteins are involved in the stabilization of Complex I assembly
intermediates and it has been proposed that even Complex III
subunits may act in the maturation of Complex I. If this process is
impeded, because Complex III is absent, Complex I is directed to
degradation [48].
Kinetic testing using metabolic flux control analysis is a
powerful source of information on the supramolecular organization
of enzyme complexes [52,53].Metabolic Control Analysis predicts
that if a metabolic pathway is composed of distinct enzymes freely
diffusible in a dynamic organization, the extent to which each
enzyme is rate-controlling may be different and the sum of all the
flux control coefficients for the different enzymes should be equal
to unity. On the other hand, in a supercomplex, the metabolic
pathway would behave as a single enzyme unit, and inhibition of
any one of the enzyme components would elicit the same flux
control. In particular, in a system in which the respiratory chain is
totally dissociated from other components of the oxidative
phosphorylation apparatus (i.e., ATP synthase, membrane
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submitochondrial particles (SMP), the existence of a su-
percomplex would elicit a flux control coefficient near unity at
any of the respiratory complexes, and the sum of all coefficients
would be above 1 [54].
Inhibitor titration experiments in isolated mitochondria from
the yeast Saccharomyces cerevisiae led to the conclusion that the
respiratory chain consists of supermolecular assemblies. Under
physiological conditions, neither ubiquinone nor cytochrome c
exhibits pool behaviour implying that the respiratory chain in
yeast is one functional and physical unit, all respiratory com-
plexes having a control coefficient of one on respiration [35].
The problem was also addressed in mammalian and in plant
mitochondria. The flux control coefficients of the complexes
involved in NADH oxidation (I, III, IV) and in succinate oxi-
dation (II–IV) were investigated in our laboratory using bovine
heart mitochondria and submitochondrial particles devoid of
substrate permeability barriers. Both Complex I and III were
found to be highly rate-controlling over NADH oxidation, a
strong kinetic evidence suggesting the existence of functionally
relevant association between the two complexes. On the
contrary, Complex IV appears randomly distributed, although
it is possible that if any stable interaction with Complex IV
exists, it escaped detection, most likely due to a pronounced
abundance of molecules in non-assembled form. Moreover,
Complex II is fully rate-limiting for succinate oxidation, clearly
indicating the absence of substrate channelling toward Com-
plexes III and IV [23].
Respiration has special features in plant cells; the mitochon-
drial respiratory chain is branched at the level of ubiquinone
owing to the presence of at least five additional so-called “al-
ternative” oxidoreductases which participate in electron transfer
[55,56]. Inhibitor titration experiments on the rotenone-sen-
sitive and rotenone-insensitive respiration in permeabilized mi-
tochondria from freshly harvested potato tubers (alternative
oxidase absent) indicate that Complex III and IVare involved in
the formation of a supercomplex assembly comprising Complex
I, whereas the alternative dehydrogenases, as well as the mole-
cules of Complex II, are considered to be independent structures
within the inner mitochondrial membrane (unpublished obser-
vations from our laboratory).
2.2. Supercomplexes and the Coenzyme Q pool
A critical appraisal of the supercomplex model requires its
reconciliation with previous kinetic and morphological evi-
dence that was largely in favour of a random distribution of the
complexes.
Morphological evidence by freeze-fracture electron micros-
copy [24,33] always showed the majority of the intramembrane
particles to have a random distribution, with little evidence for
organized aggregations; the size of the particles does not seem
to be compatible with that of large super-complexes. Never-
theless, it is not possible from microscopy alone to attain quan-
titative evaluation of the size of the proteins visualized as intra-
membrane particles. The presence of very large aggregates of
the respirasome type seems to be excluded by the freeze-frac-ture electron microscopic appearance, however smaller super-
complexes such as Complex I–Complex III units would pro-
bably be indistinguishable from Complex I monomers. One
possible explanation would be that the manipulations required
for freeze-fracture microscopy dissociate large, relatively un-
stable, assemblies allowing detection of only individual com-
plexes or smaller aggregates.
The pool equation is only valid if CoQ behaves as a homo-
geneous diffusible pool between all reducing enzymes (Vred)
and all oxidizing enzymes (Vox) [27]: is this compatible with the
existence of preferential associations? Stoichiometric channel-
ling of CoQ between Complex I and Complex III [34,39] would
exclude the bulk of the CoQ pool from kinetic determination
and would therefore be incompatible with the pool behaviour.
Thus, in presence of preferential associations, the pool equation
would be experimentally validated only if the rate of associa-
tion/dissociation of the complexes were faster than the rate of
electron transfer between complexes and CoQ molecules in the
pool.
On the other hand, the bound inter-complex quinone that
allows electron flow directly from Complex I to Complex III
may well be in dissociation equilibrium with the CoQ pool, so
that its amount, at steady state, would be dictated by the size of
the pool, i.e., by CoQ concentration: this equilibrium would
explain the saturation kinetics for total ubiquinone exhibited by
the integrated activity of Complex I and Complex III [29] and
the decrease of respiratory activities in mitochondria fused with
phospholipids with subsequent dilution of the CoQ pool [33].
To be in agreement with the experimental observation obtained
by metabolic flux analysis, this proposition must however re-
quire that the dissociation rate constants (koff) of bound CoQ be
considerably slower than the rates of inter-complex electron
transfer (for CoQ reduction by Complex I and its reoxidation by
Complex III) via the same bound quinone molecules (Fig. 2). To
this purpose, Ragan and Heron [57] in reconstitution experi-
ments of Complexes I and III at different stoichiometries de-
monstrated that CoQ reduced by Complex I in a supercomplex
does not interact at significant rates with free Complex III units
by indicating that its dissociation in the pool, if any, must be
very slow.
In order to explain the high apparent Km found for CoQ in
NADH oxidase activity [29] also kon for CoQ binding to Com-
plex I must be slow.
On the contrary, Complex II kinetically follows pool be-
haviour in reconstitution experiments [29] and in the double
inhibitor titration experiments [58], in complete accordance
with the lack of supercomplexes found by both BN-PAGE [22]
and flux control analysis [23]. Since a substantial amount of
Complex III molecules appear to be not associated with Com-
plex I, it is likely that CoQH2 reduced by Complex II prefer-
entially reacts with those free complexes.
Other enzymes necessarily needing collisional interactions
of CoQ molecules from the pool with Complex III, although no
direct demonstration exists, may well be glycerol-3-phosphate
dehydrogenase, ETF dehydrogenase, dihydroorotate dehydro-
genase, that are likely to be in minor amounts and strongly rate-
limiting in integrated electron transfer.
Fig. 2. Scheme of a possible mechanism for the dissociation equilibrium of the
bound inter-complex quinone with the CoQ pool. In order to conciliate functional
evidences for substrate channelling and saturation kinetics for total ubiquinone
exhibited by the integrated activity of Complex I and Complex III, the dissociation
rate constants of bound inter-complex ubiquinone (Q) and ubiquinol (QH2) are
assumed to be considerably slower than the rates of electron transfer via the same
quinonemolecules in the I–III supercomplex. The existence of an alternative site of
QH2 binding in Complex I is hypothetically envisaged for reverse electron transfer
from succinate to NAD+ (cf. text for comments).
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to NAD+, involving sequential interaction of Complexes II and
I by means of CoQ, must take place by collisional interactions
in the CoQ pool, since no aggregation exists between Com-
plexes I and II (cf. Fig. 2). This observation poses a particularly
puzzling question: if Complex I is completely or almost com-
pletely associated with Complex III [22,39], and the interaction
of CoQ with the quinone-binding site in common between the
two enzymes is necessarily slow (see above), then how can
CoQH2 reduced by Complex II interact from the pool with the
CoQ site in Complex I at a rate compatible with the steady state
kinetics of reverse electron transfer? The intriguing idea that
Complex I may possess two different quinone-binding sites for
direct and for reverse electron transfer respectively is com-
patible with the proposal by Vinogradov [59] that two different
routes exist for forward and reverse electron transfer within the
Complex. These two sites might become alternatively accessi-
ble depending on the magnitude of the membrane potential.
Alternatively, one should postulate that the association rate
constant of reduced CoQ from the pool to Complex I in the
supercomplex should be sufficiently fast to be compatible with
the turnover of reverse electron transfer.
The free diffusing CoQ is also likely to represent the main
antioxidant species in the innermitochondrialmembrane, where it
can break up the radical chain reaction of lipid peroxidation [60].
2.3. Role of lipids in supercomplex formation and dissociation
Early experiments reported by Ragan and Heron [57] provided
evidence that purified Complex I and Complex III, when mixed as
concentrated solutions in detergent and then co-dialysed, combine
reversibly in a 1:1 molar ratio to form a Complex I–III unit(NADH-cytochrome c oxidoreductase) that contains equimolar
FMN and cytochrome c1 and 2–3 mol of Ubiquinone-10 per mol
of protein unit. Transfer of reducing equivalents to or from this unit
by extra Complex I or Complex III molecules is slow and does not
contribute to the overall rate of electron transfer from NADH
to cytochrome c. Moreover, activation-energy measurements
for NADH-cytochrome c oxidoreductase activity showed that
oxidoreduction of endogenous Ubiquinone-10 proceeds some-
what differently from the oxidation and the reduction of exogenous
quinones, supporting the idea that the mobility of Ubiquinone-10
in the Complex I–III unit is highly restricted and suggesting that
CoQ10 is effectively trapped between the component complexes in
an environment that may be partly protein and partly derived from
the lipid annuli of those complexes.
However, Q-pool behaviour could be restored and Complex
I and Complex III could be made to operate independently of
each other by raising the concentrations of phospholipid and
ubiquinone (approx. a 2-fold and a 6-fold increase, respectively)
in the concentrated mixture [61]. Inclusion of phospholipid into
the reconstituted system may have a number of effects on the
physical state of the system. Heron et al. [61] have proposed that
the principal difference lies in the relative mobility of the
reconstituted complexes; when phospholipid in excess of that
needed to form an annulus is absent, relative mobility is lost and
complexes are frozen in their Complex I–III assembly favou-
ring a stable orientation of the site of reduction of ubiquinone
with respect to the site of oxidation. Apparently, the idea that the
respiratory complexes are associated in fixed assemblies may
sound incompatible with the presence of phospholipids in the
natural inner mitochondrial membrane; nevertheless it is worth
mentioning that inner–outer membrane contacts and the quasi-
solid organization of the matrix [62] may keep the integral
proteins in a clustered immobilized arrangement thus favouring
segregation of most of the phospholipids into separated patches.
Heron and coworkers also reported that endogenous Ubi-
quinone-10 leaks out of the Complex I–III unit when extra phos-
pholipid is present, causing a decrease in activity that could be
alleviated by adding more ubiquinone [61]. It is likely that the
function of the large amount of ubiquinone in the naturalmembrane
may be, therefore, to maintain the ubiquinone-10 content in the
supercomplex unit when it is formed.
An analogous system, obtained by fusing a crude mitochondrial
fraction (R4B) enriched in Complex I and Complex III with dif-
ferent amounts of phospholipids and CoQ10, was used to discri-
minate whether the reconstituted protein fraction behaves as
individual enzymes (Q-pool behaviour) or as assembled super-
complexes depending on the average distances experimentally
induced between the intramembrane particles. The comparison of
the experimentally determined NADH-cytochrome c reductase
activity with the values expected by theoretical calculation ap-
plying the pool equation showed overlapping results at phos-
pholipid dilutions (w/w) from 1:10 on, i.e., for distances N50 nm,
whereas at shorter distances between Complex I and Complex III,
resembling the mean nearest neighbour distance between res-
piratory complexes in mitochondria [63,64], pool behaviour was
not effective any more [65,66]. In the two experimental models,
kinetic testing according to the Metabolic flux Control Analysis
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pholipids content and of a functional association between Com-
plex I and Complex III at low phospholipids content (unpublished
results from our laboratory).
The formation of the supercomplex I–III is conditioned by the
lipid component, but the role played by the lipid environment, in
terms of its chemical composition, is not completely known.
All purified preparations of mitochondrial electron transfer
complexes are isolated as lipoprotein complexes, the extent of
associated lipid depending upon the particular method used for
isolation. Complete extraction of phospholipid from the lipo-
protein complexes revealed a gross phospholipid composition
reflecting that for the mitochondrial inner membrane; predomi-
nant phospholipids present include cardiolipin, phosphatidylcho-
line, phosphatidylethanolamine and lesser amounts of neutral
lipids and phosphatidylinositol [67].
Two roles of phospholipid have been distinguished: (i) a
dispersive solubilisation effect that can be duplicated by appro-
priate detergents; and (ii) a catalytic effect that can be specifically
fulfilled only by cardiolipin [68–71]. Indeed, there are yet two
more possible roles that may need to be met, particularly in the
case of Complex I and Complex III. These roles might be to
provide a sufficiently lipophilic environment for the interaction of
the lipophilic electron carrier, ubiquinone, and to participate in
linking together components of the respiratory chain.
The phospholipids in closest vicinity to the protein surface, as
well as those in the free bilayer, are actually highly mobile and
free to exchange, but cardiolipin was indicated as tightly bound
being more likely buried within the protein complexes [72–74].
The absolute requirement of cardiolipin (CL) for cytochrome
oxidase, Complex I and Complex III activities suggests that this
phospholipid plays a crucial role in the coupled electron transfer
process [69], but recent results seem also to indicate that car-
diolipin stabilizes respiratory chain supercomplexes as well as
the individual complexes. The availability of a CL-lacking yeast
mutant (Δcrd1 null) provided the opportunity to demonstrate
that mitochondrial membranes still contained the III2–IV2 su-
percomplex, but that it was significantly less stable than super-
complexes in the parental strain. The other phospholipids, that
increase in the mutant in substitution of lacking CL, including
phosphatidylethanolamine and phosphatidylglycerol, could not
substitute for cardiolipin in preventing dissociation of super-
complexes, showing 90% of the individual homodimers of Co-
mplex III and IV not organized into supercomplex under BN-
PAGE conditions [75,76]. The putative direct protein–protein
interaction of cytochrome oxidase and Complex III is proposed
to involve the domain formed by transmembrane helices of cy-
tochromes b and c1 and the core components of Complex IV,
namely COX1, COX2 and COX3 [75]. In the structure of yeast,
the membrane imbedded domain of Complex III forms a
depression and two phospholipid molecules, i.e., cardiolipin and
phosphatidylethanolamine, are tightly bound in this cavity [74],
suggesting that they can provide a flexible linkage between the
above mentioned subunits of Complexes III and IV.
It is well documented that exposure ofmitochondria to reactive
oxygen species (ROS) can affect the respiratory activity via
oxidative damage of cardiolipin which is required for the optimalfunctioning of the enzyme complexes [77–79]. Circumstantial
evidence from our laboratory suggests that dissociation of respira-
tory supercomplexes occurs in proteoliposomes, due to lipid
peroxidation induced by 2,2′-azobis-(2-amidinopropane)dihy-
drochloride (AAPH) before reconstitution of a protein fraction
enriched with Complex I and III (R4B) into the phospholipid
vesicles (unpublished data).
2.4. Pathological implications
The involvement of mitochondria in a variety of pathological
aspects and in aging [80–84] has been largely ascribed to their
central role in production of Reactive Oxygen Species (ROS)
and to the damaging effect of ROS on these organelles. In par-
ticular, damage to mitochondrial DNA (mtDNA) would induce
alterations of the polypeptides encoded by mtDNA in the respi-
ratory complexes, with consequent decrease of electron transfer
activity, leading to further production of ROS, and thus esta-
blishing a vicious circle of oxidative stress and energetic decline
[85,86]. This fall of mitochondrial energetic capacity is consi-
dered to be the cause of aging and age-related degenerative di-
seases [83,84,86,87]. This vicious circle might be broken by
agents capable to prevent a chain reaction of ROS formation and
damage, such as CoQ in its reduced form [60].
The observation that lipid peroxidation disrupts the aggre-
gation of Complexes I and III (see above) has profound pa-
thophysiological implications, since ROS produced by the
mitochondrial respiratory chain induce a progressive peroxida-
tion of mitochondrial phospholipids [60], and in particular of
cardiolipin [77,78] in aging and ischemic diseases, with demo-
nstrated decreased activity of both Complexes I and III [79,88].
It is tempting to speculate that under the above conditions, a
dissociation of Complex I–III aggregates occurs, with loss of
facilitated electron channelling and resumption of the less effi-
cient pool behaviour of the free ubiquinone molecules. Although
no direct demonstration exists yet, dissociation of super-
complexes might have further deleterious consequences, such
as disassembly of Complex I and III subunits and loss of electron
transfer and/or proton translocation; we could not even exclude
that the consequent alteration of electron transfer may elicit
further induction of ROS generation. The observation that Com-
plex III alterations prevent proper assembly of Complex I has
therefore deep pathological implications beyond the field of
genetic mitochondrial cytopathies.
Following this line of thought, the different susceptibility of
different types of cells and tissues to ROS damage may depend,
among other reasons, on the extent and tightness of super-com-
plex organization of their respiratory chains, that depend on their
hand on phospholipids content and composition of their mito-
chondrial membranes.
3. Mechanism of superoxide production by Complex I
3.1. On the site of univalent oxygen reduction
Complex I is generally considered as the major enzyme
contributing to generation of ROS in mitochondria; the site of
Table 2
Effect of Complex I inhibitors on the rates of ROS formation and DCIP reduction a
Inhibitor Concentration (μM) ROS generation DCIP reduction
Rotenone 1 ++++ Inhibition
Rolliniastatin-1,-2 30 ++ ND
Piericidin A 30 ++ ND
Myxothiazol 50 ++ ND
Stigmatellin 50 − No inhibition
Mucidin 60 − ND




a Assays performed in bovine heart submitochondrial particles. ROS formation
was measured in particles supplemented with NADH both fluorimetrically by the
DCFDA assay [161] and spectrophotometrically using Amplex Red [162]. DCIP
reduction was measured in a dual wavelength spectrophotometer at 600–700 nm
using an extinction coefficient of 21 mM−1 cm−1, after subtraction of the DPI-
insensitive rate (corresponding to the DCIP reduction by FMN in Complex I).
ND=not determined.
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and the reason is in part in the scant knowledge of themechanism
of electron transfer within the enzyme prosthetic groups (for
reviews on ROS production by mitochondria cf. ref. [19,89–
94]). The physiological relevance of ROS generation by Com-
plex I as well as by different mitochondrial sites is still uncertain
and is even questioned by some investigators [95].
Recently, using different Complex I inhibitors to functionally
dissect the enzyme, it was suggested that an iron–sulphur
cluster, presumably N2 [96,97], but also N1a [98] could be the
site of electron leak; however, also ubisemiquinone [99,100]
and FMN [101–106] were proposed as electron donors to oxy-
gen. In addition, it was found that the production of reactive
oxygen species (ROS) is enhanced in defective Complex I [18],
suggesting that structural modifications of the enzyme may play
a crucial role in the ROS production process.
The superoxide production by Complex I is higher during the
reverse electron transport from succinate to NAD+ [92,100,107–
110], whereas during the forward electron transport it is much
lower. Reverse electron transfer-supported ROS production
requires high membrane potential and is inhibited by uncouplers
and by processes dissipating membrane potential [108–111].
Rotenone has been found to enhance ROS formation during
forward electron transfer [96,97] and to inhibit it during reverse
electron transfer [98,100,105].
3.1.1. Novel findings from our laboratory
We have exploited the ability of Complex I to transfer electrons
directly to molecular oxygen with the aim to elucidate not only the
site of electron escape in Complex I but also the mechanism of
electron transfer inside the enzyme. To this purpose, we have tested
the effects of different inhibitors on the radical production from
Complex I, detected by fluorescence of dichlorofluorescin dia-
cetate (DCFA), that is deacylated by mitochondria and submito-
chondrial particles. The findings provide evidence on a strikingly
differential effect of two classes of Complex I inhibitors, based on
their ability to affect oxygen radical production by the enzyme
(unpublished results from our laboratory; cf. Proceedings of the
Symposium “Bari International Conference onMitochondria, from
molecular insight to physiology and pathology, Abstract L5-4).
(1) Class A inhibitors, that induce a strong increase in the
ROS production from Complex I.
(2) Class B inhibitors, that completely prevent ROS produc-
tion from the enzyme.
Class A inhibitors include Rotenone, Piericidin A, Rollini-
astatin-1 and -2, but also myxothiazol, while Class B includes
Stigmatellin, Capsaicin, Mucidin at high concentration, and also
short ubiquinone analogues such as Coenzyme Q2. Accurate
controls have excluded for these compounds a generic effect as
free radical scavengers. The effects of inhibitors on ROS forma-
tion and DCIP reduction (see below) are summarized in Table 2.
Most of Class B inhibitors are also classical Complex III
inhibitors acting at the so called center “o” where they block
electron transfer from ubiquinol to the Rieske protein; other
inhibitors of this class are short chain quinones like CoQ2,known to be poor electron acceptors from Complex I on which
they exert an inhibitory effect ascribed to the quinol form [112].
Starting from available knowledge from the literature and
from the results described in this work, we can propose the
following. Class A inhibitors prevent access of the physiolog-
ical CoQ10 from the CoQ ramp [13] to its reduction site, thus
allowing the CoQ reductant to release one electron to oxygen
instead. On the other hand, Class B inhibitors appear to directly
act on the site of oxygen reduction.
3.1.2. Identification of the site of superoxide production
The identification of the oxygen reducing site has been the
subject of extensive investigation, and several prosthetic groups
in the enzyme have been suggested to be the direct reductants of
oxygen (Table 3).
3.1.2.1. Flavin. A major candidate as the electron donor to
oxygen has been proposed to be FMN [101,102,105]; the ratio-
nale for such identification has been that diphenylene iodonium
(DPI), an inhibitor of Complex I at the FMN region, blocks
reverse electron transfer-supported ROS formation [101]; how-
ever, DPI also inhibits NADH-supported ROS formation ([101],
and unpublished data from our laboratory). Recently Brandt
[106] showed that ROS production was still present in a mutant
Complex I from Yarrowia lipolytica lacking iron sulphur cluster
N2, concluding a direct involvement of FMN in this activity. On
the other hand, Ohnishi and coworkers [99] showed that DPI
enhances ROS production in the reverse electron transfer, while
inhibiting it in the forward electron transfer. The loss of ROS
detection in presence of DPI seems to exclude any involvement
of FMN in ROS production to advantage of a direct involvement
of iron–sulphur clusters. In fact DPI inhibits the iron–sulphur
clusters reduction while the reduced state of protein-bound FMN
is stabilized [113]. Indeed, the FMN involvement in ROS pro-
duction still remains an open question and the discrepancies in
the literature should be at least in part ascribed to difficulty in
achieving complete inhibition of the NADH-O2 activity: the
inhibition of Complex I activity was never more than 80–85%,
allowing a residual electron flux to iron sulphur clusters. Herrero
Table 3
Postulated sites of superoxide generation in Complex I
Site of ROS production Detection method Experimental evidences References
FMN Fluorescence determination of p-HPAA
in presence of HRP




adrenaline oxidation to adrenochrome
Spectrophotometric determination of
acetylated cytochrome c reduction
Rotenone and piericidin prevent formation of iron–sulfur




acetylated cytochrome c reduction
Wild type and a mutant Complex I (lacking a detectable iron–
sulfur cluster N2) from Yarrowia lipolytica exhibit the same





Fluorescence determination of Amplex
Red oxidation in presence of HRP
In forward electron transfer ROS production is enhanced by
rotenone and piericidin A and inhibited by DPI and
ethoxyformic anhydride.
[99]
In reverse electron transfer DPI, ethoxyformic anhydride and
Piericidin A enhance ROS production, suggesting that the
major site of superoxide generation is protein-associated
ubisemiquinones spin-coupled with cluster N2.
Spectrophotometric determination of
adrenaline oxidation to adrenochrome
The rotenone-stimulated superoxide production is inhibited
by both p-chloromercuribenzoate and ethoxyformic
anhydride indicating that oxygen radical generator is located




adrenaline oxidation to adrenochrome
p-hydroxy-mercuribenzoate inhibits ROS generation while
inhibitors acting as quinone antagonists enhance it. CoQ
depletion does not inhibit ROS production, in agreement
with N2 as ROS production site.
[96]
Fluorescence determination of Amplex
Red oxidation in presence of HRP
The redox properties of reduced FMN exclude it as the ROS
generator. The ROS production enhanced by rotenone and
inhibited by p-chloromercuriobenzoate is consistent with a
ROS site located on N-1a centre.
[98]
Fluorescence determination of p-
HPAA in presence of HRP
ROS production in reverse electron transport is strongly
dependent on ΔpH. Between the three ubisemiquinone
species found inside the enzyme only the SQNf exhibits
sensitivity to ΔpH, so it might be the direct reductant of
oxygen in Complex I.
[100]
Fluorescence determination of DCFA Differential action of two classes of Complex I inhibitors on
ROS production in SMP treated with NADH.
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transfer in Complex I was also inhibited by ethoxyformic anhy-
dride, an inhibitor of iron sulphur clusters, clearly excluding
FMN as the site of oxygen reduction. In addition, the studies by
Lambert and Brand [100] and by Ohnishi et al. [99] also exclude
FMN as the reductant of oxygen, pinpointing a site close to or
coincident with the CoQ-binding site (see below). Our unpu-
blished study also excludes flavin as the site of oxygen reduc-
tion, since it would be incompatible with our present finding of
the differential action of two classes of inhibitors both acting
downstream of the iron sulphur clusters in the enzyme. Never-
theless, a major role can be envisioned for FMN in the formation
of radical species by Complex I in the presence of physiologi-
cal hydrophilic quinones (i.e., cathecolamine-derived oxidative
products). The mechanism through which adrenochrome was
shown to enhance the formation of ROS by Complex I is a
multiple-step process involving a site situated upstream in theredox-active chain of the enzyme, likely coincident with a FMN,
since the reaction is insensitive to both rotenone and p-hy-
droxymercuribenzoate [114].
3.1.2.2. Ubisemiquinone. One of the possible candidates is the
ubisemiquinone species. Brand [100] excludes any site upstream
of the quinone/semiquinone couple itself on the basis of the
significant differences found in the stimulating effects of
rotenone, piericidin and myxothiazol on ROS production:
since all these are inhibitors of the CoQ site, the sites upstream
of CoQ should have been affected to the same extent by the
different inhibitors. However, with the same reasoning, it is not
possible to exclude the electron donor(s) to CoQ, such as N2,
that share the CoQ site. Ohnishi et al. [99] reach similar
conclusion from the differential effects of rotenone and pieri-
cidin in both forward and reverse electron transfer, and conclude
that cluster N2 and/or ubisemiquinones bound to cluster N2 may
Fig. 3. Hypothetical mechanism of electron transfer in the quinone acceptor
region of Complex I indicating the site of oxygen reduction to superoxide.
Scheme A would explain the differential action of hydrophobic inhibitors (cf.
text for explanations) but is not compatible with the effects of the inhibitors on
DCIP reduction nor is in line with current knowledge on their sites of action.
Scheme B better explains the findings of the effects of the inhibitors on both
oxygen and DCIP reduction. Cf. text for detailed discussion.
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by the Onhishi group [11] it appears that Complex I inhibitors
such as Rotenone and Piericidin A turn off the EPR signal from
the semiquinones species. Unfortunately there is no available
evidence about the effects of the other Complex I inhibitors on
the EPR semiquinone signals. From our unpublished results on
the ROS production it appears that inhibitors known to shut
down the semiquinone signal are also most efficient in the direct
transfer of electrons to molecular oxygen. These results would
suggest that the endogenous semiquinone formed during the
redox cycle of the enzyme is not involved in ROS production.
This conclusion is also in line with a previous report showing
that in CoQ-depleted mitochondria Complex I is able to produce
oxygen radicals at a rate comparable with the enzyme in non-
extracted mitochondria [96].
3.1.2.3. Iron sulphur clusters. Another major candidate as the
direct oxygen reductant is the iron sulphur cluster N2; according
to Brandt [115,116] this site is localized at the interface between
the matrix site and the membranous part of the enzyme. The
recent crystallographic identification of the steric location of all
iron sulphur clusters of the bacterial enzyme [14] allows to
locate N2 more precisely, closer to the membrane sector of the
enzyme than previously suggested.. Because of its midpoint
potential higher than that of the other clusters, N2 is considered
as the direct electron donor to the ubiquinone. It is commonly
accepted that Complex I inhibitors share the same hydrophobic
large pocket binding site in the enzyme [16] and, according to
the structural model proposed by Brandt et al. [17], this pocket
could be the amphipathic ‘ramp’ guiding ubiquinone into the
catalytic site. In this picture Rotenone and related inhibitors
would prevent the quinone access to the catalytic site, but would
not prevent the reduction of N2 cluster.
The electron transfer from NADH to ubiquinone in Complex I
requires the presence of at least eight iron–sulphur clusters, seven
of which are well protected from reacting with oxygen with the
exception of N2. From structural and functional studies, the iron–
sulphur cluster N2 seems to be localized in a region that should be
accessible to protein bound ubisemiquinones, to H+ ions and to
water, hence this region should be also accessible to molecular
oxygen. On the other hand, the mid point potential of cluster N2 is
around −0.15 to −0.05 V [117] and therefore, it is compatible with
the reduction of oxygen to superoxide anion (mid point potential
for the couple superoxide/oxygen is −0.14 V [99]. The correct
value of the midpoint potential for the superoxide/oxygen couple
[99]makes less stringent the identification of a group having lower
potential such as cluster N1a [98] and flavin itself (see above).
Our unpublished results outlined above seem to agree with
the hypothesis indicating the cluster N2 as the direct reductant
of molecular oxygen. Anyway, during normal redox cycle, the
electron leak from Complex I is very low: it can be increased by
the presence of Class A inhibitors while it is not related to the
reduced state of the enzyme. In fact in presence of 1.8 μM
Mucidin, that inhibits Complex III and prevents radical forma-
tion from it without affecting the Complex I activity, and at
saturating concentrations of NADH (condition that allows the
full reduction of all redox centres in Complex I as well as thereduction of the quinone pool [26]), the superoxide production
was enhanced only to a minor extent. On the other hand, when
Mucidin was used at 60 μM concentration, we could achieve
full inhibition of the NADH-CoQ1 activity together with a full
inhibition of ROS production even in presence of Class A
inhibitors. These results suggest that the presence of Class B
inhibitors is sufficient to prevent the electron escape from
Complex I even in the presence of Class A inhibitors. It might
be guessed that they induce in the enzyme a conformational
change that makes the reducing center more accessible to mo-
lecular oxygen, whereas Class B inhibitors would either directly
block this reducing center, or induce a conformational change
making it less accessible.
3.1.3. Mechanism of electron transfer in the CoQ region of
Complex I
Two minimal schemes of electron transfer in Complex I are
compatible with these findings (Fig. 3A, B). In a linear scheme
(Fig. 3A), the electron donor to oxygen is presumably Fe–S
cluster N2, whose reduction by the preceding cluster is inhibited
by stigmatellin whereas its reoxidation is inhibited by rotenone.
In a bifurcated scheme (Fig. 3B), the first electron is delivered to
CoQ with formation of semiquinone in a rotenone sensitive
way; semiquinone is then reduced to quinol by N2 in a stig-
matellin-sensitive way. N2 is also the donor to oxygen; rotenone
does not prevent delivery of one electron to N2 and then to
oxygen, while stigmatellin prevents electron delivery to either
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with the position of the stigmatellin-inhibition site downstream
with respect to the rotenone site, since the behaviour of stig-
matellin is shared by reduced quinone analogs [13].
A further confirmation of this scheme derives from the effect of
inhibitors on reduction of the acceptor dichlorophenol indophenol
(DCIP) (unpublished results from our laboratory). Some DCIP is
reduced at the level of FMN, since there is a component insensitive
to DPI; another component is sensitive to DPI and must be reduced
at the level of CoQ. In fact both hydrophilic and hydrophobic
quinones enhance DPI-sensitive DCIP reduction. The reduction is
inhibited by rotenone but only slightly by stigmatellin.
These findings demonstrate that DCIP is reduced at a site
situated between the rotenone and the stigmatellin inhibition sites,
a further indication for a split pathway of electrons at the CoQ
binding site. According to the scheme presented in Fig. 3B, DCIP
would be reduced by ubisemiquinone, since its formation is
rotenone sensitive but stigmatellin insensitive.
The presence of a bifurcated pathway for CoQ reduction has
to be reconciled with the linear pathway of electrons along the
series of iron sulphur clusters as demonstrated by the crys-
tallographic study of Sazanov [14]; our interpretation is not in
contrast with the existence of a linear pathway, because the two
electrons delivered to CoQ for its complete reduction could well
be provided alternatively by two different clusters (or even by
the same cluster) if a suitable conformational change occurs
after the first electron delivery in order to provide a gating
mechanism for the second electron.
3.2. Implications for human pathology
Humans are exposed to a great number of Complex I inhi-
bitors, since numerous insecticides and pesticides belong to this
category [13,118]. The aetiology of Parkinson's disease, though
uncertain, may include chronic exposure to such compounds
either in adulthood or during development [119,120], in asso-
ciation with genetic susceptibility [121–124]; epidemiological
studies [124–127], the effects of inhibitors in animal models of
the disease [128–131] and the known involvement of Complex
I defect in Parkinson patients [132] support the idea that envi-
ronmental exposures and genetic mitochondrial dysfunction
may interact and result in neurodegeneration. The ability of
some of these inhibitors to elicit generation of excess oxygen
radicals may aggravate the damage induced by inhibition of
electron transfer. Thus, knowledge of the capacity of the long
list of compounds acting as Complex I inhibitors to induce
oxidative stress has important practical implications.
Genetic alterations of Complex I subunits may alter electron
transfer mimicking the effect of a Complex I inhibitor: thus,
some alterations may induce overproduction of ROS while
others might depress the oxygen radical production. Several
examples of enhanced ROS production in genetic defects of
Complex I are known in the literature, particularly for nuclear
genes mutations [133,134], whereas the effect of mitochondrial
gene mutations is less clear [135–137]; recently, cybrids carrying
the LHON 14487 ND6 mutation were shown to undergo a ROS
overproduction [138]. Also, physiological states, such as subunitphosphorylation, may modify the ROS generating capacity of
Complex I [139,140]. It is therefore tempting to speculate that
endocrine alterationsmay affect the capacity ofROS formation by
hyper- or hypo-phosphorylation of the Complex.
Mitochondrial DNA mutations have been consistently found
in cancerous cells [84,141]; they have been found to be associated
with enhanced ROS production, and ROS act both as mutagens
and cellular mitogens [142]; thus the involvement of mtDNA
mutations in cancer may well be of pathogenic importance [84].
In a recent study, we have shown that a cell line of a malignant
thyroid oncocytoma, characterized by abnormal mitochondrial
proliferation [143], contains a mutation of mitochondrial DNA
preventing expression of subunit ND1 [144]. These cells exhibit
a dramatic decline of ATP synthesis supported by NAD-depen-
dent substrates, while in the mitochondria isolated from these
cells the Complex I activity is strongly depressed (unpublished
observations). Accordingly, the cell line produces much higher
amounts of ROS compared with a line derived from a non-
oncocytic thyroid tumor [145]. It is relevant to quote the recent
finding [146] that Complex I defects induce mitochondrial
outgrowth as a consequence of increased ROS production. It is
tempting to speculate that the abnormal mitochondrial prolifer-
ation characteristic of these tumours is due to stimulation by
ROS of mitochondrial proliferation.
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